Pfizer recalls that are postponed for three weeks in all regions, lastly Lazio. And new reservations that already incorporate the second dose at 42 days as suggested by the Technical-Scientific Committee in an opinion contained in a recent circular from the Ministry of Health. Yesterday Valeria Marino, medical director of Pfizer Italy, recommended sticking to the initial approach because it would ensure the same coverage results as the agencies have assessed for the drug: The vaccine was designed for a second administration at 21 days. Data on a longer range of administration at the moment we have none except in real life observations.
A claim that triggers a short circuit with requests of clarification to the Health Department led by Roberto Speranza. Just two days ago both Lombardy and Lazio had dismantled the last resistances by agreeing to reschedule the bites to meet the new strategy of Commissioner Francesco Figliuolo which It is more useful to vaccinate the largest audience as soon as possible of population using all available supplies. System confirmed yesterday in the meeting held with the Regions, where the general remarked that on the timing of the administrations the point of reference are the pronouncements of the Cts, even if it was decided to leave the 21-day indication for cancer patients unchanged. Lazio took advantage of it for recover 100,000 Pfizer doses which had been blocked by reopening membership for over 50s and deciding to divert part of AstraZeneca and J&J vials to over 40s ahead of the nation. With an agreement with general practitioners and pharmacies from Monday 17 May it will be possible to book.
Vaccines in Italy and Europe: the news
A leap forward that signals vaccination federalism which risks delaying the immunization of many over 60s who are not yet covered. In Lazio 700 thousand people would be involved waiting for the second dose. Some have been alerted to the three-week postponement, others are awaiting confirmation. Everyone is confused by this unexpected alert from the pharmaceutical company. The will – made explicit in the summit with the Regions – would be that of adopt a shared strategy without leaks forward, opening to company vaccinations no earlier than June and following the age criterion up to 50 years. 9.2 million Italians await the recall. If we calculate that for AstraZeneca there are about 1.2 million waiting, it means that for Pfizer and Moderna we now have about 8 million waiting. For Pfizer alone, calibrating the supplies of these weeks, they would be approximately 7.2 million. Waiting for the two vaccines, there are over 3.3 million over 70s, about 2.7 million over 60s and 600,000 over 80s.
The opinion of the CTS on the lowering is also expected shortly 50 years of the preferential threshold for AstraZeneca, currently stopped at 60 years.
May 11, 2021 (change May 12, 2021 | 00:15)
© REPRODUCTION RESERVED